Innovent’s Mazdutide 9 mg Moves One Step Closer to...
Category : Clinical Trial Update 28 November 2025China may soon have a powerful new option for treating moderate to severe obesity. Innovent Biologi...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Chugai’s Port Delivery System Hits Key Milestone i...
Category : Clinical Trial Update 28 November 2025A New Long-Term Treatment Option for nAMD and DME Patients Chugai Pharmaceutical has reported res...
Novo Nordisk’s Amycretin Delivers Strong Phase 2 R...
Category : Clinical Trial Update 28 November 2025Novo Nordisk has revealed positive Phase 2 results for amycretin, a new dual-agonist targeting GLP-1...
Otsuka Files NDA for Centanafadine, a First-in-Cla...
Category : Clinical Trial Update 27 November 2025Otsuka has taken a major step in ADHD innovation. The company has filed a New Drug Application (NDA)...
NeuroSense Secures FDA Clearance to Launch Pivotal...
Category : Clinical Trial Update 27 November 2025NeuroSense Therapeutics has hit a major milestone. The FDA has cleared the company to begin its pivo...
Latest Newsletter Post
-
Novo Nordisk’s Amycretin Delivers S..
28 November 2025
-
Chugai’s Port Delivery System Hits..
28 November 2025
-
Innovent’s Mazdutide 9 mg Moves One..
28 November 2025
-
Lighthouse Pharmaceuticals Showcase..
27 November 2025
-
NeuroSense Secures FDA Clearance to..
27 November 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com